THE LONG TERM GOAL IS TO DEVELOP A SAFE AND EFFECTIVE VACCINE FOR GONORRHAE.

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$47,982.00
Award Year:
1984
Program:
SBIR
Phase:
Phase I
Contract:
n/a
Agency Tracking Number:
1357
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Immunomed Corpon
4904 West Cypress Street, Tampa, FL, 33607
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
JOHN C. MCMICHAEL
SENIOR SCIENTIST
() -
Business Contact:
() -
Research Institution:
n/a
Abstract
THE LONG TERM GOAL IS TO DEVELOP A SAFE AND EFFECTIVE VACCINE FOR GONORRHAE. FIRST, OUR AIM IS TO DEVELOP AN IN VIVO MODEL SYSTEM FOR GONORRHAE. THE EYE OF THE RABBIT, PARTICULARLY AFTER SOME FORM OF TRAUMTIZATION, IS REPORTED TO BE SUSCEPTIBLE TO INFECTION AND IS OUR PROPOSED MODEL SYSTEM. SECOND, IS TO CHARACTERIZE THE IMMUNE RESPONSE TO THE PILAR COMMON ANTIGENIC DETERMINANT. IN THIS PART OF THE STUDY THE PRODUCTION OF DIFFERENT CLASS IMMUNOGLOBINS WILL BE ACHIEVED, REASONING THAT THE PRODUCTION OF SECRETORY IMMUNOGLOBINS SHOULD BE MOST PROTECTIVE MECHANISM. THIRD, WILL BE TO DETERMINE THE PROTECTIVE EFFECT OF THE PILAR COMMON ANTIGEN AGAINST VIRULENT N. GONORRHAEAE WITH DIFFERENT SEROTYPES OF PILI. THIS WILL BE CARRIED OUT AFTER THE DEVELOPMENT OF THE IN VIVO ANIMAL MODEL. NEXT, THE COMMON ANTIGENIC STRUCTURES OF N. GONORRHAEAE WILL BE ANALYZED AND IN THE CASE OF THE PILAR COMMON ANTIGENIC SITES THE PARTICULAR AMINO ACID SEQUENCE WILL BE INVESTIGATED FOR PROTECTIVE ACTIVITY. THIS PROJECT WOULD BE A PRELUDE TO ACTUAL TESTING OF A PILI SUBUNIT VACCINE IN HUMANS.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government